Schedule 13G ownership disclosure

AILERON THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A105

Event date: 2019-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,542,288
Percent of class
5.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-19-000097
Form type
SC 13G/A
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Nov 08, 2019
Reporting period
Oct 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub